• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监狱中耐多药结核病的患病率:系统评价与荟萃分析。

Prevalence of multidrug-resistant tuberculosis in prisons: Systematic review and meta-analysis.

作者信息

Moreira Tiago Ricardo, Passos Ibsen Barguine Junqueira, Bueno João Vitor L, Maffacciolli Rosana, Colodette Renata Maria, Miguel Paulo Sérgio

机构信息

Doutor e Saúde Pública. Departamento de Medicina e Enfermagem, Universidade Federal de Viçosa, Viçosa-MG, Brazil.

Graduado Em Medicina. Departamento de Medicina e Enfermagem, Universidade Federal de Viçosa, Viçosa-MG, Brazil.

出版信息

Indian J Med Microbiol. 2022 Apr-Jun;40(2):193-199. doi: 10.1016/j.ijmmb.2022.01.004. Epub 2022 Feb 1.

DOI:10.1016/j.ijmmb.2022.01.004
PMID:35120789
Abstract

BACKGROUND

In the context of prisons, multidrug-resistant tuberculosis (MDR-TB) is a major problem. In this article, we estimate the prevalence of MDR-TB among the population deprived of freedom from countries in South America, Europe, Asia and Africa.

METHODS

The articles were retrieved through systematic search at four databases (EMBASE, CINAHL, LILACS and MEDILINE). The meta-analysis was developed by the random effect model, using the Mantel-Haenszel method, with presentation of the aggregated results through the forest plot. The degree of heterogeneity between the studies was verified using Cochran's Q test and I.

RESULTS

Of the 102 articles analyzed, 21 were included in this systematic review. The analysis showed heterogeneity indicated by the Q test (P ​< ​0.001) and I statistics (I ​= ​50.52%). The funnel graph and Egger test (P ​< ​0.830) showed symmetry between investigations. The grouped prevalence of MDR-TB was 0.48% (95% CI: 0.02 to 1.32), advancing to 1.15 (95% CI: 0.15 to 2.73) when culture and sensitivity test were considered by the authors. No specific characteristics were significantly associated with differences in prevalence rates in the population deprived of freedom.

CONCLUSION

The study reaffirms the magnitude of MDR-TB in the population deprived of freedom in the world context. Political and technical-scientific efforts should be mobilized to mitigate TB and MDR-TB in prisons and for successful national and international disease control programs.

摘要

背景

在监狱环境中,耐多药结核病(MDR-TB)是一个主要问题。在本文中,我们估计了南美洲、欧洲、亚洲和非洲国家被剥夺自由人群中的耐多药结核病患病率。

方法

通过在四个数据库(EMBASE、CINAHL、LILACS和MEDILINE)进行系统检索来获取文章。采用随机效应模型,使用Mantel-Haenszel方法进行荟萃分析,并通过森林图展示汇总结果。使用Cochran's Q检验和I统计量来验证研究之间的异质性程度。

结果

在分析的102篇文章中,有21篇被纳入本系统评价。分析显示Q检验(P < 0.001)和I统计量(I = 50.52%)表明存在异质性。漏斗图和Egger检验(P < 0.830)显示各研究之间具有对称性。耐多药结核病的合并患病率为0.48%(95%置信区间:0.02至1.32),当作者考虑培养和药敏试验时,该患病率升至1.15(95%置信区间:0.15至2.73)。没有特定特征与被剥夺自由人群中患病率的差异显著相关。

结论

该研究再次证实了在全球范围内被剥夺自由人群中耐多药结核病的严重程度。应调动政治和技术科学方面的努力,以减轻监狱中的结核病和耐多药结核病,并推动国家和国际疾病控制项目取得成功。

相似文献

1
Prevalence of multidrug-resistant tuberculosis in prisons: Systematic review and meta-analysis.监狱中耐多药结核病的患病率:系统评价与荟萃分析。
Indian J Med Microbiol. 2022 Apr-Jun;40(2):193-199. doi: 10.1016/j.ijmmb.2022.01.004. Epub 2022 Feb 1.
2
Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.移民人群中耐多药结核病治疗依从性:系统评价和荟萃分析。
BMC Med. 2018 Feb 22;16(1):27. doi: 10.1186/s12916-017-1001-7.
3
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
4
Risk factors for multidrug resistant tuberculosis in Europe: a systematic review.欧洲耐多药结核病的危险因素:一项系统综述
Thorax. 2006 Feb;61(2):158-63. doi: 10.1136/thx.2005.045963. Epub 2005 Oct 27.
5
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
6
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.症状和胸部 X 线筛查在 HIV 阴性的成年人和 HIV 状态未知的成年人中的活动性肺结核。
Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2.
7
Couple therapy for depression.针对抑郁症的夫妻治疗。
Cochrane Database Syst Rev. 2018 Jun 8;6(6):CD004188. doi: 10.1002/14651858.CD004188.pub3.
8
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.
9
Heated tobacco products for smoking cessation and reducing smoking prevalence.加热烟草制品戒烟和降低吸烟率。
Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Prison as a driver of recent transmissions of multidrug-resistant tuberculosis in Callao, Peru: a cross-sectional study.秘鲁卡亚俄监狱作为耐多药结核病近期传播的驱动因素:一项横断面研究
Lancet Reg Health Am. 2024 Jan 20;31:100674. doi: 10.1016/j.lana.2024.100674. eCollection 2024 Mar.